Investor profile
GV has backed 35 European tech companies across 43 funding rounds between 2017 and 2026, joining rounds totalling €5.1B. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Isomorphic Labs | UK | 2 | €2.3B |
| Recursive Superintelligence | UK | 1 | €555M |
| Synthesia | UK | 3 | €302M |
| Nothing | UK | 2 | €233M |
| Multiverse | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Isomorphic Labs | Series B | €1.8B | 2026-05 |
| Recursive Superintelligence | Other | €555M | 2026-05 |
| Isomorphic Labs | Other | €555M | 2025-03 |
| Multiverse |
| 1 |
| €205M |
| Genesis | UK | 1 | €176M |
| Leyden Labs | Netherlands | 2 | €164M |
| Scandit | Switzerland | 1 | €131M |
| Tessl | UK | 1 | €119M |
| OMass Therapeutics | UK | 1 | €90M |
| Ultromics | UK | 2 | €76M |
| GoCardless | UK | 1 | €66M |
| Snyk | UK | 1 | €63M |
| Verve Therapeutics | United States | 1 | €56M |
| Lawhive | UK | 1 | €51M |
| Buena | Germany | 1 | €49M |
| Attio | UK | 1 | €45M |
| SolveAI | UK | 1 | €42M |
| Again | Denmark | 1 | €39M |
| Blockchain | Luxembourg | 1 | €36M |
| Resistant AI | Czech Republic | 2 | €36M |
| Anomali | UK | 1 | €33M |
| Gravity Sketch | UK | 1 | €31M |
| Vacchitech | UK | 1 | €23M |
| Nanit | Israel | 1 | €21M |
| nPlan | UK | 1 | €16M |
| Nym Health | Israel | 1 | €14M |
| Push Security | UK | 1 | €14M |
| deepset | Germany | 1 | €13M |
| MokN | France | 1 | €13M |
| Series D+ |
| €205M |
| 2022-06 |
| Genesis | Series C | €176M | 2022-02 |
| Synthesia | Series D+ | €175M | 2025-01 |
| Nothing | Other | €169M | 2025-09 |
| Scandit | Series D+ | €131M | 2022-02 |
| Leyden Labs | Series B | €124M | 2022-01 |
| Tessl | Series A | €119M | 2024-11 |
